Phalanx Biotech Group

Phalanx Biotech Group is a Taiwan-based biotechnology company focused on genomic analysis tools and research services. It was established in 2002 through collaboration among Taiwan's Industrial Technology Research Institute, private companies, and research institutes. The company is headquartered in Hsinchu and has been associated with operations or service presence in San Diego, Shanghai, and Beijing, giving it an international footprint across Taiwan, the United States, and China. The company's principal commercial platform is OneArray, a registered trademark used for its DNA microarray products and related service offerings. OneArray arrays are designed for gene-expression profiling and microRNA profiling. The product portfolio includes whole-genome arrays for human, mouse, rat, and yeast research, as well as microRNA arrays covering human, rodent, model-organism, and plant applications. These tools are intended for researchers investigating gene activity, regulatory pathways, disease mechanisms, biological responses, and other questions in molecular biology and life-science research. Phalanx's technology is based on a non-contact inkjet process for depositing intact oligonucleotides onto standard glass microscope slides measuring 25 by 75 millimeters. The company describes this process as using patented dispensing and deposition technology. In addition to manufacturing arrays, Phalanx provides laboratory and analytical services, allowing customers to outsource experimental work rather than purchase and operate the underlying platform themselves. Its service offering extends beyond the OneArray platform. Available services include Agilent microarray services, quantitative polymerase chain reaction, PCR-array profiling, and next-generation sequencing. These laboratory services can be paired with customized bioinformatics analysis, enabling researchers to move from sample processing and data generation to interpretation in a single workflow. This combination positions Phalanx as both a supplier of research consumables and a contract provider of genomics experimentation and analysis. Phalanx Biotech Group has also participated in the U.S. Food and Drug Administration-led MicroArray Quality Control Project. That association places the company within broader efforts to assess the reproducibility and quality of microarray-based gene-expression measurements. The company is therefore best understood as a specialized life-science tools and services brand rather than a pharmaceutical manufacturer or a consumer-facing healthcare company. Its business is directed primarily toward academic, biotechnology, pharmaceutical, diagnostic, and other research users requiring high-throughput molecular profiling.

Phalanx Biotech Group emerged in Taiwan in 2002 from a collaborative initiative involving the Industrial Technology Research Institute, private-sector participants, and research institutions. Its formation reflected the development of Taiwan's biotechnology and advanced manufacturing capabilities, particularly in the production of research tools for molecular biology. The company developed a business around DNA microarrays, which allow researchers to measure the activity of many genes in parallel. It commercialized these products and associated services under the OneArray trademark. The platform expanded beyond a single organism or application: whole-genome arrays were made available for human, mouse, rat, and yeast studies, while microRNA products addressed human, rodent, model-organism, and plant research. This breadth allowed the company to serve diverse experimental programs in genomics and gene regulation. Phalanx's manufacturing approach uses non-contact inkjet deposition to place intact oligonucleotides on standard glass slides. The company has described the deposition apparatus and related process as patented technology. This manufacturing capability formed the technical foundation of its microarray business and differentiated its role from companies that only resell third-party laboratory products. Alongside product sales, Phalanx built a service model for customers that needed genomic data without establishing their own microarray or sequencing infrastructure. Its service portfolio included OneArray experiments, Agilent microarray work, qPCR, PCR-array profiling, and next-generation sequencing. The company also offered bioinformatics packages that could be tailored to the project, extending its involvement from wet-laboratory processing into data analysis and interpretation. The company's locations and service presence in Hsinchu, San Diego, Shanghai, and Beijing supported its international orientation. Its participation in the FDA-led MicroArray Quality Control Project further connected it with industry and public-sector work concerning the reliability and comparability of microarray measurements. Publicly available reference material emphasizes the company's platform, manufacturing process, and research services; it does not provide sufficient information to document a detailed sequence of later ownership changes, executive appointments, financial results, or major corporate transactions.

1. 2002Company established

   Phalanx Biotech Group was founded through collaboration involving Taiwan's Industrial Technology Research Institute, private companies, and research institutes.

   Source
2. OneArray platform developed

   The company introduced its OneArray-branded DNA microarray and microRNA profiling products and related services for multiple species and research applications.

   Source
3. Participation in MicroArray Quality Control Project

   Phalanx became a participant in the U.S. Food and Drug Administration-led MicroArray Quality Control Project.

   Source

A specialized genomics tools and contract-research provider combining microarray products with outsourced molecular profiling, sequencing, and bioinformatics services.

• OneArray DNA microarraysGene-expression profiling

  OneArray DNA microarrays are used to measure the expression of large numbers of genes in parallel. The portfolio includes whole-genome products for human, mouse, rat, and yeast research. The arrays are manufactured by depositing intact oligonucleotides onto standard glass slides through a non-contact inkjet process.

• OneArray microRNA microarraysMicroRNA profiling

  OneArray microRNA arrays support profiling of microRNAs in human, rodent, model-organism, and plant studies. They are offered as products and as part of laboratory services, enabling researchers to examine small regulatory RNAs across different biological systems.

• Microarray profiling servicesContract genomics services

  Phalanx provides outsourced microarray experiments using its OneArray platform and Agilent arrays. The service model is intended for customers that need sample processing and expression or microRNA profiling without operating their own array laboratory.

• qPCR and PCR-array profiling servicesMolecular biology services

  The company offers quantitative PCR and PCR-array profiling as complementary methods for targeted gene analysis and validation. These services broaden its offering beyond discovery-oriented microarrays and can be combined with project-specific analytical support.

• Next-generation sequencing servicesSequencing services

  Phalanx also provides next-generation sequencing services. Sequencing projects may be accompanied by customizable bioinformatics packages, linking data generation with downstream computational processing and interpretation.

• Bioinformatics packagesBioinformatics

  Bioinformatics support is available alongside the company's profiling and sequencing services. The packages are described as customizable, allowing analysis to be matched to the platform, organism, study design, and research objectives.

1. Phalanx Biotech Group